A patient on a tyrosine-kinase inhibitor develops bleeding with a normal platelet count and normal PT/aPTT, but thromboelastography shows a reduced maximum amplitude. What is the most appropriate treatment?
A
Transfuse 6 units of cryoprecipitate
B
Administer desmopressin 0.3 mcg/kg IV
C
Transfuse 1 unit of apheresis platelets
D
Administer aminocaproic acid 5 g IV
A new question appears every day. Bookmark this page or share it with a colleague.